Mochida Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	734	697	700	809	1,049	1,265
Market Cap Growth	-0.53%	-0.51%	-13.49%	-22.82%	-17.09%	-7.46%
Enterprise Value	562	365	434	396	595	797
Last Close Price	20.40	19.16	18.42	21.27	24.61	29.20
PE Ratio	21.05	19.83	25.13	17.58	13.38	19.12
PS Ratio	1.21	1.07	1.11	1.13	1.28	1.59
PB Ratio	0.98	0.86	0.89	0.92	1.10	1.29
P/TBV Ratio	0.99	0.87	0.90	0.93	1.11	1.30
P/FCF Ratio	-	15.67	-	22.78	31.64	22.61
P/OCF Ratio	-	12.05	-	16.02	18.96	17.85
EV/Sales Ratio	0.92	0.56	0.69	0.55	0.73	1.00
EV/EBITDA Ratio	8.98	5.35	8.23	5.12	4.70	7.02
EV/EBIT Ratio	12.23	7.28	12.21	6.73	5.58	8.62
EV/FCF Ratio	-	8.22	-	11.15	17.95	14.25
Debt / Equity Ratio	0.07	-	-	-	-	-
Net Debt / Equity Ratio	-0.23	-0.39	-0.37	-0.48	-0.48	-0.50
Net Debt / EBITDA Ratio	-2.75	-4.62	-5.43	-5.41	-3.62	-4.30
Net Debt / FCF Ratio	-	-7.11	4.79	-11.79	-13.85	-8.74
Asset Turnover	0.64	0.66	0.65	0.64	0.68	0.65
Inventory Turnover	1.67	1.62	1.86	2.03	2.21	2.02
Quick Ratio	2.72	3.32	3.13	3.24	3.14	3.23
Current Ratio	4.01	4.81	4.47	4.31	4.07	4.14
Return on Equity (ROE)	4.80%	4.40%	3.57%	5.21%	8.27%	6.93%
Return on Assets (ROA)	3.02%	3.19%	2.28%	3.30%	5.54%	4.70%
Return on Invested Capital (ROIC)	8.48%	7.14%	5.81%	9.41%	16.01%	14.10%
Return on Capital Employed (ROCE)	5.50%	6.00%	4.40%	6.50%	10.80%	9.00%
Earnings Yield	4.75%	5.04%	3.98%	5.69%	7.47%	5.23%
FCF Yield	-	6.38%	-8.56%	4.39%	3.16%	4.42%
Dividend Yield	2.33%	2.58%	2.66%	2.60%	2.71%	2.37%
Payout Ratio	-	49.87%	63.49%	50.71%	32.59%	36.14%
Buyback Yield / Dilution	0.00%	1.15%	3.49%	2.47%	1.37%	1.23%
Total Shareholder Return	2.33%	3.73%	6.15%	5.08%	4.08%	3.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.